Ad is loading...
ADNRX vs RRMGX
ADNRX vs RRMGX Comparison
Open Charts ADNRX vs RRMGX
American Beacon ARK Transfmt Innov R6
Price$16.27
Change-$0.03 (-0.18%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth R
Price$88.92
Change-$0.05 (-0.06%)
VolumeN/A
CapitalizationN/A
ADNRX vs RRMGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. RRMGX commentary
Dec 25, 2024
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Hold and RRMGX is a Buy.
FUNDAMENTALS
Fundamentals
RRMGX has more cash in the bank: 30.6B vs. ADNRX (217M). ADNRX (0.00) and RRMGX (0.00) have matching dividends . ADNRX was incepted earlier than RRMGX: ADNRX (4 years) vs RRMGX (22 years). ADNRX is a more actively managed with annual turnover of: 33.00 vs. RRMGX (21.70). ADNRX has a lower initial minimum investment than RRMGX: ADNRX (0) vs RRMGX (2500). ADNRX annual gain was more profitable for investors over the last year : 12.21 vs. RRMGX (-0.57).
| ADNRX | RRMGX | ADNRX / RRMGX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 4 years | 22 years | - |
| Gain YTD | 13.301 | -0.892 | -1,492% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 217M | 30.6B | 1% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 12.21 | -0.57 | -2,141% |
| Returns for 3 years | -43.19 | -15.95 | 271% |
| Returns for 5 years | N/A | 0.05 | - |
| Returns for 10 years | N/A | 21.94 | - |
View a ticker or compare two or three
VS
VS
Ad is loading...